These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 8754536

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Indications for the use of tactivin in the combined treatment of phlegmons of the maxillofacial area].
    Drobyshev VIu, Volozhin AI, Agapov VS, Sashkina TI.
    Stomatologiia (Mosk); 1996; 75(4):27-30. PubMed ID: 8992659
    [Abstract] [Full Text] [Related]

  • 3. [Clinical and experimental bases for using dibasol in inflammatory diseases of the maxillofacial area].
    Alekhova TM.
    Stomatologiia (Mosk); 1982; 61(1):15-7. PubMed ID: 6950550
    [No Abstract] [Full Text] [Related]

  • 4. [Use of a chloracetophos ointment in the combined treatment of acute odontogenic inflammatory processes of the maxillofacial area].
    Khamitov FS, Faizov TT, Berim MG.
    Stomatologiia (Mosk); 1985; 64(1):35-7. PubMed ID: 3857735
    [No Abstract] [Full Text] [Related]

  • 5. [The clinico-laboratory assessment of the efficacy of dalargin in treating acute suppurative-inflammatory processes of the maxillofacial area].
    Bazhanov NN, Ganina SS, Pashutin SB, Ragimov ChR.
    Sov Med; 1991; (7):29-31. PubMed ID: 1948337
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The efficacy of preparations with antioxidant action in the combined treatment of phlegmons of the maxillofacial area].
    Ragimov ChR.
    Stomatologiia (Mosk); 1992; (3-6):35-7. PubMed ID: 1307152
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The use of the preparation baliz-2 in inflammatory processes of the maxillofacial area].
    Bernadskaia GP, Timofeev AA, Kutsenko TA.
    Stomatologiia (Mosk); 1989; 68(6):10-1. PubMed ID: 2623675
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The use of tactivin for treating patients with IHD].
    Klimov AN, Almazov VA, Nagornev VA, Denisenko AD, Pigarevskiĭ PV, Ogurtsov RP, Sergeeva EG, Sitnikova OD, Popov VG.
    Ter Arkh; 1995; 67(9):24-7. PubMed ID: 7495034
    [Abstract] [Full Text] [Related]

  • 19. [A clinico-immunological assessment of the efficacy of combined methods of treating patients with different immunopathological forms of focal scleroderma].
    Suchkova TN, Sharova NM, Suchkov SV.
    Vestn Dermatol Venerol; 1990; (2):47-50. PubMed ID: 2343669
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.